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Nuclear Factor B Signaling Either Stimulates or Inhibits
Neurite Growth Depending on the Phosphorylation Status of
p65/RelA
Humberto Gutierrez,* GerardW. O’Keeffe,* Nu´ria Gavalda`, Denis Gallagher, and AlunM. Davies
School of Biosciences, Cardiff University, Cardiff CF10 3US, United Kingdom
Nuclear factor B (NF-B) signaling is known to promote neurite growth from developing sensory neurons and to enhance the size and
complexity of pyramidal neuron dendritic arbors in the developing cerebral cortex. In marked contrast, here we show that NF-B
signaling can also exert a potent inhibitory influence on neurite growth in certain neurons, and can either promote or inhibit neurite
growth in the same neurons depending on the mechanism of NF-B activation. In neonatal superior cervical ganglion sympathetic
neurons, enhancing NF-B transcriptional activity by overexpressing either the p65 NF-B subunit or the IB kinase- (IKK) subunit
of the IB kinase complex, or by tumor necrosis factor (TNF) treatment, strongly inhibits neurite growth. Paradoxically in neonatal
nodose ganglion sensory neurons, enhancing NF-B transcriptional activity by p65/p50 overexpression increases neurite growth,
whereas enhancing NF-B transcriptional activity by IKK overexpression inhibits neurite growth. In addition to activating NF-B,
IKK overexpression leads to phosphorylation of p65 on serine 536. Blockade of serine 536 phosphorylation by a S536A-p65 mutant
protein prevents the growth-inhibitory effects of IKK overexpression in both sensory and sympathetic neurons and the growth-
inhibitory effects of TNF on sympathetic neurons. Furthermore, expression of a p65 S536D phosphomimetic mutant inhibits neurite
growth fromsensoryneurons.These resultsdemonstrate thatNF-Bcaneither stimulateor inhibit neurite growth indevelopingneurons
depending on the phosphorylation status of p65.
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Introduction
Nuclear factor B (NF-B) is a ubiquitously expressed transcrip-
tion factor system that consists of homodimers or heterodimers
of five structurally related proteins: p65 (RelA), RelB, c-Rel, p50,
and p52. NF-B dimers are held in an inactive form in the cytosol
by interaction with a member of the IB family of inhibitory
proteins: IB, IB, IB, IB, Bcl-3, p100, and p105. The
p65/p50 heterodimer is the most abundant and widely expressed
form of NF-B, and IB is the predominantly expressed inhib-
itor. In the classical NF-B signaling pathway, NF-B is activated
by phosphorylation of IB on Ser32 and Ser36 by the IB
kinase- (IKK) catalytic subunit of an IB kinase (IKK) com-
plex that consists of IKK together with another catalytic subunit
IKK and a regulatory subunit IKK. This leads to ubiquitina-
tion and proteasome-mediated degradation of IB and translo-
cation of the liberated NF-B to the nucleus where it binds to B
elements in the promoter and enhancer regions of responsive
genes, resulting in gene induction or gene repression (Perkins,
2007).
NF-B has been studied most extensively in the immune sys-
tem in which it plays a key role in regulating the expression of
genes involved in innate and adaptive immune responses, inflam-
matory responses, cell survival, and cell proliferation (Liang et al.,
2004). In the nervous system, NF-B is activated by a variety of
neurotrophic factors, cytokines, and neurotransmitters, and has
been implicated in regulating neuronal survival and death, pe-
ripheral nerve myelination, and synaptic function (Me´met,
2006). NF-B is also emerging as an important positive regulator
of axonal and dendritic growth in developing peripheral and cen-
tral neurons. NF-B signaling contributes to cortical pyramidal
dendrite growth and to the neurite growth-promoting effects of
NGF and brain-derived neurotrophic factor (BDNF) in PC12
cells and sensory neurons, respectively (Sole et al., 2004; Gutier-
rez et al., 2005), and is critical for ciliary neurotrophic factor
(CNTF)-promoted neurite growth from sensory neurons (Gal-
lagher et al., 2007).
In the present study, we investigated the roles of NF-B sig-
naling in two well characterized populations of peripheral neu-
rons of newborn mice. Sympathetic neurons of the superior cer-
vical ganglion (SCG) survive and extend neurites in response to
NGF (Glebova and Ginty, 2005), whereas sensory neurons of the
nodose ganglion survive and extend neurites in response to
BDNF (Gutierrez et al., 2005). We report that enhanced NF-B
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signaling inhibits neurite growth from
sympathetic neurons, in contrast to its
growth-promoting effects in sensory neu-
rons. Furthermore, we show that this
functional reversal in the role of NF-B is
determined by the phosphorylation status
of a single residue in p65 that can be
brought about by differential engagement
of the IKK complex in these two neuronal
populations.
Materials andMethods
Neuron culture and transfection. Dissociated
cultures of nodose ganglion or SCG neurons
from newborn mice were grown in
polyornithine/laminin-coated 35 mm tissue
culture dishes in defined medium and were
transfected 3 h after plating with plasmid-
coated gold microcarriers using the Bio-Rad
Gene-gun (Gutierrez et al., 2005). In all exper-
iments, except those involving SN50, the neu-
rons were transfected with a yellow fluorescent
protein (YFP) expression plasmid to identify
transfected neurons and visualize their neurite
arbors for analysis by confocal microscopy. The
microcarriers were also coated with pcDNA3.1
plasmid(s) expressing the required protein(s),
as specified for each set of experiments.
Control-transfected neurons received
pcDNA3.1 containing a short sequence of non-
coding DNA. For experiments using B decoy
DNA, neurons were transfected with the YFP
plasmid together with decoy or control oligo-
nucleotides as described previously (Gutierrez
et al., 2005).
SCG neurons were grown in medium con-
taining 10 ng/ml NGF (R&D Systems), and no-
dose neurons were grown in medium contain-
ing 10 ng/ml BDNF (R&D Systems). Where
indicated, 10 ng/ml tumor necrosis factor 
(TNF) (R&D Systems) or 20 M of either
SN50 or the SM control peptide (Calbiochem)
were added to the medium. Neuronal survival
was estimated after 24 h in culture as described
previously (Gutierrez et al., 2005).
Quantification of NF-B activity. To estimate
the relative level of NF-B activation, neurons
were transfected with a plasmid expressing
green fluorescent protein (GFP) under the con-
trol of an NF-B promoter. Neurons were im-
agedwith aCarl Zeiss Axioplan confocalmicro-
scope, and mean soma fluorescence intensity
was obtained using LSM510 software (Gutier-
rez et al., 2005).
Analysis of neuritic arbors. YFP-labeled neu-
rons, or in the case of experiments using SN50
in which the neurons were fluorescently labeled
with the vital dye calcein-AM (Invitrogen), were visualized and digitally
acquired using an Axioplan Carl Zeiss laser-scanning confocal micro-
scope. Neuritic arbors were traced using LSM510 software from which
total neurite length and number of branch points were calculated and
Sholl analysis performed (Gutierrez and Davies, 2007).
Western blots. In all experiments, neurons were plated at high density
in polyornithine/laminin-coated 96-well plates (5000 neurons per well).
Three hours after plating, 10 ng/ml NGF for SCG neurons or 10 ng/ml
BDNF for nodose neurons was added to the wells for the indicated times.
TNF (10 ng/ml) was added where indicated. The cells were lysed in
radioimmunoprecipitation buffer, and insoluble debris was removed by
centrifugation. Samples were transferred to polyvinylidene difluoride
membranes using the Bio-Rad TransBlot (Bio-Rad). The membranes
were blocked with 5% dried milk in PBS with 0.1% Tween 20 and were
incubated with either anti-phospho-Ser IB- (1:1000; Abcam), anti-
IB (1:1000; Abcam), anti-phospho-S536-p65 (1:1000; Cell Signaling
Technology), anti-phospho-IKK (1:1000; Cell Signaling Technology),
anti-IKK (1:1000; Cell Signaling Technology), anti-p65 (1:1000; Cell Sig-
nalingTechnology), or anti-III-tubulin (1:10,000; Promega) antibodies
that were detected with peroxidase-linked secondary antibodies (1:2000;
Promega) and ECL-plus (GE Healthcare). Densitometry was performed
using Adobe Photoshop.
Figure 1. Blockade of NF-B signaling does not prevent neurite growth from SCG neurons. A–E, Shown are bar charts of
NF-B-dependent transcriptional activity (A) and Sholl plots of the neurite arbors of P0 SCG neurons in which different steps in
NF-B signalingwere inhibitedby transfectionwithanS32A/336A IBplasmid (B), transfectionwithaY42A IBplasmid (C),
treatmentwith 20M SN50 (D), or transfectionwithB decoy DNA (E). Controls were transfectedwith a pcDNA3.1 plasmidwith
a noncoding insert (B, C), treatedwith 20MSMcontrol peptide (D), or transfectedwith scrambled sequence oligonucleotide (E).
Neurons were cotransfected with the B-GFP reporter for measuring transcriptional activity and with the YFP plasmid for Sholl
analysis (except for the SN50/SM experiments in which the neurite arbors were labeled with calcein-AM). All data were obtained
24hafter transfection (performed3hafter plating) or SN50/SM treatment (added1hafter plating). The combined results of three
separate experiments are plotted (means and SEs of the data from150 neurons for each condition). Statistically significant
differences from controls are indicated (**p 0.001).
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Immunocytochemistry. Cultured neurons were fixed in ice-cold meth-
anol for 5 min, washed with PBS, blocked with 5% BSA in PBS, and
incubated with anti-phospho-S536-p65 antibody (1:50; Cell Signaling
Technology) at 4°C for 18 h. After washing, neurons were incubated with
anti-rabbit-Cy3 secondary antibody (Alexa Fluor; Invitrogen; 1:500) and
counterstained with 4,6-diamidino-2-phenylindole (DAPI) (Millipore
Bioscience Research Reagents). Neurons were imaged with a Carl Zeiss
Axioplan confocal microscope and mean soma fluorescence intensity
was obtained using LSM510 software (n40 neurons per experimental
condition taken from three independent experiments).
Results
Blockade of NF-B signaling does not affect neurite growth
from SCG neurons
To assess the requirement for NF-B signaling in the growth of
neurites from developing sympathetic neurons, we inhibited sev-
eral different steps in the NF-B signaling network in SCG neu-
rons cultured from newborn mice and quantified the size and
complexity of neurite arbors after 24 h incubation with NGF. In
all cases, we assessed the effectiveness of NF-B inhibition by
transfecting the neurons with a plasmid expressing GFP under
the control of an NF-B promoter and compared fluorescence
intensity in experimental and control neurons (Gutierrez et al.,
2005; Gallagher et al., 2007). We also quantified neuronal sur-
vival in all experiments to ascertainwhether any of the treatments
adversely affected survival. We previously showed that BDNF
does not influence NF-B activation in postnatal nodose gan-
glion sensory neurons (Gutierrez et al., 2005). We repeated the
same experiment in postnatal SCG neurons and found that NGF
likewise does not affect NF-B activation in these neurons (data
not shown).
We reported in nodose neurons that constitutive activation of
NF-B significantly contributes to BDNF-promoted neurite
growth (Gutierrez et al., 2005). Here, we selectively inhibited
NF-B signaling by the classic pathway in postnatal SCGneurons
by transfecting these neurons with a plasmid that expresses a
mutated IB proteinwith serine-to-alanine substitutions at res-
idues 32 and 36 (Roff et al., 1996). Although neurons expressing
this S32A/S36A IB mutant displayed a marked reduction in
NF-B reporter signal compared with control-transfected neu-
rons (Fig. 1A), this protein had no effect on the neurite arbor size
and complexity, as shown by Sholl analysis, which provides a
graphic representation of neurite branching with distance from
the cell body (Fig. 1B). Measurements of total neurite length and
Figure 2. Enhancing NF-B signaling inhibits neurite growth from SCG neurons. P0 SCG neurons were transfected 3 h after plating with the YFP plasmid together with one or more of the
following plasmids as specified in the figure: a control pcDNA3.1 plasmid with a noncoding insert, theB-GFP reporter for measuring transcriptional activity, and plasmids expressing p65, p50, or
wild-type IKK (wt IKK). A–E, Twenty-four hours after transfection, NF-B-dependent transcriptional activity was quantified (A), and neurite arbors were analyzed to measure total neurite
length (B), count the number of branch points (C), and obtain Sholl profiles (D, E). The combined results of three separate experiments are plotted (means and SEs of the data from150 neurons
for each condition). Statistically significant differences are indicated (*p 0.05; **p 0.001). F, Photomicrographs of a representative control-transfected neuron and neurons overexpressing the
proteins indicated. Scale bar, 50m.
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branch point number and counts of the number of surviving
neurons at the end of the experiment (80% of the number
plated) revealed no significant differences between S32A/S36A
IB-transfected and control-transfected neurons (data not
shown).
We also reported in nodose neurons that NF-B activation by
phosphorylation of IB at tyrosine 42 is essential for CNTF-
promoted neurite growth (Gallagher et al., 2007), and it has been
shown that NGF activates NF-B in PC12 cells via tyrosine phos-
phorylation of IB (Bui et al., 2001). This NF-B signaling
pathway was selectively inhibited in postnatal SCG neurons by
transfecting the neurons with a plasmid that expresses a Y42F
IBmutant (Imbert et al., 1996; Gallagher et al., 2007). Expres-
sion of this mutant protein caused a marked decrease in NF-B
reporter signal compared with control-transfected neurons (Fig.
1A) but did not affect the shape of the Sholl profile (Fig. 1C).
Total neurite length, branch point number, and neuronal sur-
vival were also not significantly different between Y42F IB-
transfected and control-transfected neurons (data not shown).
Translocation of activated NF-B from the cytoplasm to the
nucleus is inhibited by SN50, a cell-permeable peptide that blocks
the nuclear localization sequence of p50 (Lin et al., 1995). Al-
though SN50 caused a clear reduction in NF-B reporter signal
(Fig. 1A), there were no significant differences in the Sholl pro-
files of neurons grownwith an inactive control peptide (SM) (Fig.
1D). There were also no significant differences in total neurite
length, branch point number, and neuronal survival between
SN50-treated and SM-treated cultures (data not shown).
Finally, we investigated the consequences of blocking binding
of activated NF-B to regulatory elements in target genes by
transfecting SCG neurons with double-stranded DNA oligonu-
cleotides containing the B consensus binding sequence (Mor-
ishita et al., 1997). This B decoy DNA, but not control oligonu-
cleotides with a scrambled sequence, caused a marked reduction
in NF-B reporter signal (Fig. 1A) but did not affect the Sholl
profile (Fig. 1E). There were also no significant differences in
total neurite length, branch point number, and neuronal survival
between neurons transfected with B decoy DNA and control
DNA (data not shown).
Because neurite growth from nodose sensory neurons de-
pends on NF-B signaling during a brief developmental window
during the immediate perinatal period (Gutierrez et al., 2005), we
studied the effect of inhibiting NF-B signaling in SCG neurons
at two additional postnatal ages to see whether neurite growth
from these neurons might also depend on NF-B signaling dur-
ing an equivalent developmental window. Blockade of NF-B
Figure 3. Opposite effects of IKK overexpression and p65/p50 overexpression on neurite growth from nodose neurons. P0 nodose neurons were transfected 3 h after plating with the YFP
plasmid together with one or more of the following plasmids as specified in the figure: a control pcDNA3.1 plasmid with a noncoding insert, the B-GFP reporter for measuring transcriptional
activity, andplasmids expressingp65, p50, orwild-type IKK (wt IKK).A–E, Twenty-four hours after transfection, NF-B-dependent transcriptional activitywas quantified (A), andneurite arbors
were analyzed to measure total neurite length (B), count the number of branch points (C), and obtain Sholl profiles (D, E). All treatments were performed in the same experiments, but are shown
separately for clarity. The combined results of three separate experiments are plotted (means and SEs of the data from150 neurons for each condition). Statistically significant differences from
controls are indicated (*p 0.05; **p 0.001). F, Photomicrographs of a representative control-transfected neuron and neurons overexpressing the proteins indicated. Scale bar, 50m.
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signaling by either SN50 orBdecoyDNA in postnatal day 3 (P3)
and P6 SCG neurons had no effect on neurite growth (data not
shown). Finally, although neurite growth from postnatal SCG
cultured requires NGF, we investigated the effects of inhibiting
NF-B signaling in SCG neurons grown without NGF. In cul-
tures supplemented with caspase inhibitors to prevent apoptosis
in the absence of NGF, inhibiting NF-B signaling by any of the
above approaches had no effect on neurite growth (data not
shown). Together, the above findings demonstrate that SCGneu-
rons cultured from newborn mice have clearly detectable NF-B
transcriptional activity that can be substantially reduced by inter-
fering with IB activation by either ser32/ser36 or tyr42 phos-
phorylation, by preventing nuclear translocation of activatedNF-
B, and by sequestering transcriptionally active NF-B
complexes. None of these manipulations affects neuronal sur-
vival, and in marked contrast to hippocampal pyramidal neu-
rons, sensory neurons, and PC12 cells (Sole et al., 2004; Gutierrez
et al., 2005; Gallagher et al., 2007), none affects neurite growth,
indicating thatNF-B signaling does not promote neurite growth
in sympathetic neurons under these experimental conditions.
Enhancing NF-B signaling inhibits neurite growth from
SCG neurons
Given the surprising finding that neurite growth from SCG neu-
rons is unaffected by inhibiting NF-B signaling, we investigated
whether experimentally enhancingNF-B signaling in these neu-
rons has any effect on neurite arbor size. To this end, SCG neu-
rons were transfected with plasmids expressing the p65 and p50
NF-B subunits together with the NF-B reporter plasmid to
assess the level of NF-B-dependent transcription. Overexpres-
sion of p65 and p50 caused amarked elevation inNF-B reporter
signal (Fig. 2A) and highly significant reductions in total neurite
length and branching (Fig. 2B,C). These dramatic effects of in-
creased NF-B-dependent transcription on neurite growth are
also clearly illustrated by the Sholl profile of transfected neurons
(Fig. 2D) and by images of representative neurite arbors (Fig.
2F). Despite the marked reductions in neurite arbor size and
complexity brought about by overexpressing NF-B subunits,
there were no significant differences in the numbers of control-
transfected and NF-B-transfected neurons 48 h after transfec-
tion, indicating that overexpression of these proteins does not
adversely affect sympathetic neuron survival (data not shown).
These data show, in marked contrast to sensory neurons, that
enhancing NF-B signaling in newborn sympathetic neurons in-
hibits neurite growth in proportion to the increase in NF-B-
dependent transcription.
To confirm that the growth-inhibitory effect of overexpress-
ing NF-B subunits in sympathetic neurons results from en-
hanced NF-B-dependent transcription rather than some non-
specific consequence of overexpressing these particular proteins,
Figure 4. IKK and p65 phosphorylation in SCG and nodose neurons.A,B, RepresentativeWestern blots comparing the levels of phospho-IKK and total IKK (A) and phospho-S536-p65 and total
p65 (B) in the same quantity of total protein extracted from P0 SCG and nodose neurons 24 h after plating. C, Quantification of the relative levels of these proteins from densitometric scans of three
separate experiments of each type are plotted. D, Photomicrograph showing immunostainings of phospho-S536-p65 in cultured P0 nodose and SCG neurons 24 h after transfection with a YFP
plasmid togetherwith an IKKplasmid. DAPI nuclear staining, YFP labeling, and phospho-S536-p65 immunostaining in the same fields are shown from left to right. The bar chart shows the relative
intensity of phospho-S536-p65 immunostaining in IKK-overexpressing nodose and SCG neurons (black bars) normalized to the level in the respective control-transfected nodose and SCG neurons
(pcDNA3.1 plasmid,white bars).E, Photomicrographof immunostainings for total p65 in culturedP0nodose andSCGneurons 24hafter transfectionwith aYFPplasmid togetherwith ap65plasmid.
DAPI staining, YFP labeling, and p65 immunostaining in the same fields are shown from left to right. The bar chart shows the relative intensity of p65 immunostaining in p65-overexpressing nodose
and SCG neurons (black bars) normalized to the level in the respective control-transfected nodose and SCG neurons (pcDNA3.1 plasmid, white bars). F, Photomicrograph of immunostainings for
phospho-S536-p65 in cultured P0 nodose and SCG neurons 24 h after transfection with a YFP plasmid together with a p65 plasmid. DAPI staining, YFP labeling, and phospho-S536-p65 immuno-
staining in the same fields are shown from left to right. The bar chart shows the relative intensity of phospho-S536-p65 immunostaining in p65-overexpressing nodose and SCG neurons (black bars)
normalized to the level in the respective control-transfected nodose and SCG neurons (white bars). Means and SEs of measurements from150 neurons for each condition are shown in D–F.
Statistically significant difference from control-transfected neurons is indicated (**p 0.001).
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we overexpressed IKK to promote phosphorylation of IB, a
key substrate of IKK and an essential step in activating the clas-
sical NF-B pathway. Overexpression of IKK significantly in-
creased NF-B-dependent transcription (Fig. 2A) and greatly
reduced neurite length and branching compared with control-
transfected neurons (Fig. 2B,C,E,F). These data again show that
enhancing NF-B signaling in sympathetic neurons significantly
reduces neurite growth.
Furthermore, to ascertain whether NF-B signaling in cul-
tured SCG neurons is normally dependent on the catalytic
activity of IKK, we transfected newborn SCG neurons with a
plasmid expressing a dominant-negative 44 IKK protein.
Quantification of the NF-B reporter signal in these neurons
revealed a significant reduction compared with control-
transfected neurons, indicating that IKKmakes a significant
contribution to the basal level of NF-B signaling in cultured
newborn SCG neurons. As with blocking NF-B activation
with the S32A/336A IB mutant, expression of the 44
IKK mutant did not significantly affect neurite length and
branching and had no significant effect on survival (data not
shown). This provides additional confirmation that blockade
of NF-B signaling does not interfere with neurite growth
from newborn SCG neurons.
IKK and p65/p50 overexpression have
opposite effects in sensory neurons
Theneurite growth-inhibitory effect of en-
hancing NF-B signaling in sympathetic
neurons was particularly surprising given
the neurite growth-promoting effects of
NF-B signaling observed in sensory neu-
rons and cortical pyramidal neurons (Gu-
tierrez et al., 2005; Gallagher et al., 2007).
This finding and our demonstration that
there are no significant differences in the
basal levels of endogenousNF-B reporter
activity between sensory and sympathetic
neurons (data not shown) indicate that
NF-B can exert opposing effects on the
growth of neural processes in different
neuronal populations. To ascertain
whether these opposing effects of NF-B
signaling reflect neuron-specific differ-
ences, we explored the effects of activating
NF-B by alternative mechanisms in sen-
sory neurons. To this end, P0 nodose gan-
glion neurons were transfected with either
an IKK plasmid or both p65 and p50
plasmids. Quantification of the GFP signal
from the cotransfected NF-B reporter re-
vealed that overexpression of IKK and
p65/p50 each caused marked and similar
increases in NF-B transcriptional activity
(Fig. 3A). Analysis of neurite arbor size
and complexity 24 h after transfection re-
vealed that p65/p50 overexpression caused
significant increases in neurite length and
branching (Fig. 3B–D,F). Surprisingly,
IKK overexpression had a very marked
inhibitory effect on neurite growth (Fig.
3B,C,E,F). Neither p65/p50 overexpres-
sion nor IKK overexpression affected
neuronal survival (data not shown). These
results show that activating NF-B by dif-
ferent mechanisms can have opposing effects on neurite growth
in the same neurons, suggesting the existence of a functional
switch in the NF-B signaling network.
Selective IKK activation and p65 phosphorylation on Ser536
in SCG neurons
Our finding that IKK overexpression in nodose sensory neu-
rons switches NF-B signaling from growth-promoting to
growth-inhibitory prompted us to examine potential differences
in the basal level of activation of the IKK complex in sympathetic
and nodose neurons. For these experiments, protein extracts of
cultured newborn SCG and nodose neurons were probedwith an
anti-phospho-IKK antibody. Whereas SCG neurons had clearly
detectable levels of phospho-IKK proteins, these phosphopro-
teins were barely detectable in nodose neurons. These striking
differences in basal activation were observed after 24 h in culture
(Fig. 4A,C) and 1 h after plating (data not shown). This suggests
much higher, sustained activation of the IKK complex in sympa-
thetic neurons compared with nodose ganglion sensory neurons.
Among the substrates of the IKK complex is the p65 NF-B
subunit, which it phosphorylates on Ser536 (Sakurai et al., 1999;
Yang et al., 2003; Jeong et al., 2005; Sasaki et al., 2005). Given the
high constitutive activation of the IKK complex in sympathetic
Figure 5. TNF inhibits neurite growth from SCG neurons by an NF-B-dependent mechanism. A, B, Representative
Western blots for phosphoserine-IB- (A) and total IB- (B) in protein extracts of P0 SCG neurons treated with 10
ng/ml TNF from 5 to 120 min (0, untreated neurons) 24 h after plating. The cultures used for phosphoserine-IB-
detection received 10 mM ALLN 30 min before TNF treatment. C, Representative Western blots for phospho-IKK and
phospho-S536-p65 in protein extracts of P0 SCG neurons treated 24 h after plating with 10 ng/ml TNF for 15–30min (0,
untreated neurons). D, NF-B-dependent transcriptional activity in P0 SCG neurons transfected 3 h after plating with the
YFP plasmid and B-GFP reporter plus either the S32A/336A IB plasmid or pcDNA3.1 control plasmid and cultured for
an additional 24 h with or without 10 ng/ml TNF. E–G, Total neurite length (E), number of branch points (F ), and Sholl
profiles (G) of P0 SCG neurons transfected 3 h after plating with the YFP plasmid and either the S32A/336A IB plasmid
or pcDNA3.1 control plasmid and cultured for an additional 24 h with or without 10 ng/ml TNF. The combined results of
three separate experiments are plotted (means and SEs of the data from150 neurons for each condition). Statistically
significant differences from controls are indicated (**p 0.001).
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compared with nodose neurons, we asked
whether there are corresponding differ-
ences in the level of phospho-S536-p65 in
these neurons. Protein extracts of sympa-
thetic, but not sensory neurons, displayed
strong immunoreactivity for phospho-
S536-p65 after 24 h in culture (Fig. 4B,C)
and 1 h after plating (data not shown), also
demonstrating sustained levels of
phospho-S536-p65 in SCG neurons. To
confirm that this difference was not attrib-
utable to endogenous differences in the
basal level of NF-B activation between
sympathetic and sensory neurons, we
compared directly the NF-B reporter sig-
nal in these two neuronal populations.
These measurements revealed no signifi-
cant differences in signal intensity (SCG,
44.3  2.4 SEM; nodose, 40.8  1.56
SEM). Furthermore, no significant differ-
enceswere observedwhen the reporter sig-
nal was normalized to the fluorescence in-
tensity of a cotransfected constitutively
expressed RFP to control for potential dif-
ferences in transfection efficiency between
these two neuronal populations (SCG,
0.723  0.04 SEM; nodose, 0.848  0.12
SEM).
Activation of IKK (but not IKK)
promotes phosphorylation of p65
on Ser536
Because phospho-S536-p65 has been pro-
posed to regulate transcription of a dis-
tinctive set of target genes (Okazaki et al.,
2003; Buss et al., 2004; Sasaki et al., 2005),
our demonstration that sympathetic neu-
rons possess substantially higher levels of this form of p65 than
sensory neurons raised the possibility that S536 phosphorylation
might be responsible for switching NF-B signaling from
growth-promoting to growth-inhibiting. Given that IKK over-
expression in nodose neurons reverses the effects of NF-B acti-
vation on neurite growth, we investigated whether IKK overex-
pression leads to an elevation in the level of phospho-S536-p65 in
these neurons. Western blot analysis could not be used to assess
the level of phospho-S536-p65 in neurons overexpressing IKK
because of the low efficiency of ballistic transfection. We there-
fore used immunofluorescent detection to visualize phospho-
S536-p65 in transfected neurons using an anti-phospho-S536-
p65 antibody. Digital quantification of labeling intensity by
confocal microscopy revealed that IKK overexpression caused
marked increases in phospho-S536-p65 immunofluorescence in
both nodose neurons and SCG neurons relative to the respective
control-transfected neurons (Fig. 4D). Interestingly, nodose and
SCG neurons transfected with an IKK plasmid in place of the
IKK plasmid showed no increase in phospho-S536-p65 immu-
nofluorescence compared with control-transfected neurons
(data not shown). These findings show that overexpression of
IKK, but not IKK, enhances phosphorylation of p65 on Ser536
in both sensory and sympathetic neurons.
Because overexpression of p65/p50 in nodose and SCG neu-
rons has opposite effects on neurite growth, we askedwhether the
overexpressed dimer is differentially phosphorylated in these two
neuronal populations. To this end, cultures of newborn nodose
and SCG neurons were cotransfected with both p65 and p50
plasmids togetherwith a YFP plasmid to identify transfected neu-
rons. After 24 h, cultures were fixed and divided into two groups,
one of which was labeled for total p65 immunofluorescence and
the other for phospho-S536-p65. Both SCG and nodose neurons
overexpressing p65/p50 exhibited intense labeling for total p65
relative to nontransfected neurons and control-transfected neu-
rons (Fig. 4E). In contrast, an increase in phospho-S536-p65
immunofluorescence was only observed in SCG neurons overex-
pressing p65/p50. The level of phospho-S536-p65 immunofluo-
rescence in nodose neurons overexpressing p65/p50 was not sig-
nificantly different from nontransfected and control-transfected
neurons (Fig. 4F).
TNF inhibits neurite growth from SCG neurons by an
NF-B-dependent mechanism
To further explore the implications of the negative regulation of
neurite growth byNF-B signaling in postnatal sympathetic neu-
rons, we looked at the potential effects of TNF on NF-B sig-
naling and neurite growth in these neurons. TNF is a potent
activator of NF-B in a variety of cells (Hehlgans and Pfeffer,
2005), and TNF has been shown to act on embryonic SCG
neurons to accelerate the onset of apoptosis after NGF depriva-
tion (Barker et al., 2001). Because TNF can activate several dif-
ferent signaling pathways depending on the cellular context
Figure 6. Blocking phosphorylation of p65 at S536 in SCG neurons abolishes neurite growth inhibition induced by TNF and
p65 overexpression. A–C, Total neurite length (A), number of branch points (B), and Sholl profiles (C) of the neurite arbors of P0
SCG neurons transfected 3 h after plating with the YFP plasmid together with either a pcDNA3.1 control plasmid, p65 plasmid, or
a S536A-p65 plasmid and cultured for an additional 24 h. D–F, Total neurite length (D), number of branch points (E), and Sholl
profiles (F ) of the neurite arbors of P0 SCG neurons transfected 3 h after plating with the YFP plasmid and either the pcDNA3.1
control plasmid or S536A p65 plasmid and cultured for an additional 24 h with or without 10 ng/ml TNF. The combined results
of three separate experiments are plotted (means and SEs of the data from150 neurons for each condition). Statistically
significant difference from control-transfected neurons is indicated (**p 0.001).
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(Hehlgans and Pfeffer, 2005), we first examined whether TNF
activates the classical NF-B pathway in postnatal SCG neurons.
To ascertain whether TNF increases IB phosphorylation,
Western blots of proteins extracted from SCG neurons treated
with TNF for times ranging from5 to 120minwere probedwith
an IB phosphoserine antibody. To avoid proteosome-
mediated degradation of IB complicating the analysis of these
blots, the proteosome inhibitor N-acetyl-Leu-Leu-norleucinal
(ALLN) was included in the medium. TNF promoted amarked
increase in phosphoserine IBwithin 5min followed by a grad-
ual decline to near-prestimulation levels by 120 min (Fig. 5A). In
the absence of ALLN, Western blots showed a clear decrease in
total IB protein after 60 min followed by a characteristic NF-
B-dependent resynthesis of IB (Fig. 5B). These findings to-
gether with a substantial increase in the NF-B reporter signal in
neurons treated with TNF (Fig. 5D) demonstrate that TNF
activates NF-B in newborn SCG neurons.
Analysis of the neurite arbors of postnatal SCG neurons incu-
bated with TNF for 24 h revealed marked reductions in overall
length (45% shorter than control neurons) (Fig. 5E), in branch-
ing (61% fewer branch points) (Fig. 5F), and in the Sholl profile
(Fig. 5G). Despite its marked effect on axon growth, TNF did
not significantly affect the number of SCG neurons surviving
with NGF at this stage of development
(data not shown). To confirm that the
suppression of neurite growth by TNF
was attributable to NF-B activation,
postnatal SCG neurons were transfected
with the S32A/336A IB plasmid before
TNF treatment. Expression of this super-
repressor IB not only prevented the
TNF-induced increase in NF-B-
reporter signal (Fig. 5D) but completely
eliminated the suppression of neurite
growth by TNF (Fig. 5E–G). These re-
sults show that TNF inhibits neurite
growth from postnatal sympathetic neu-
rons by an NF-B-dependent mechanism
and confirm that NF-B signaling nega-
tively regulates neurite growth from these
neurons.
Because TNF activates IKK during
the induction of NF-B signaling, we in-
vestigated whether treating newborn SCG
neurons with TNF increases the level of
phospho-S536-p65. Western blot analysis
of proteins extracted from cultured SCG
neurons 15 and 30 min after TNF treat-
ment revealed clear increases in both
phospho-IKK (Fig. 5C) and phospho-
S536-p65 (Fig. 5C), confirming that TNF
activates IKK and enhances S536 phos-
phorylation in these neurons. Similar ex-
periments with TNFwere not performed
on nodose neurons because these neurons
do not respond to this cytokine.
Blocking phosphorylation of p65 at
S536 abolishes neurite
growth inhibition
To test directly whether enhanced phos-
phorylation of p65 on S536 is responsible
for the growth-inhibitory effect of NF-B
activation in SCG and nodose neurons, we transfected these neu-
rons with a plasmid that expresses a p65 protein with a serine-to-
alanine substitution at residue 536 that prevents phosphorylation
at this site but does not abolish the transcriptional activity of p65
(Okazaki et al., 2003; Buss et al., 2004; Sasaki et al., 2005). Expres-
sion of this S536A-p65 mutant had no effect on the survival of
either nodose or SCG neurons (data not shown) and caused a
significant, more than twofold increase in B reporter signal in
both kinds of neurons ( p  0.0001) (data not shown). Despite
enhancing NF-B transcriptional activity in sympathetic neu-
rons, expression of this S536A-p65mutant, unlike overexpressed
wild-type p65, failed to inhibit neurite growth (Fig. 6A–C) and
completely abolished the neurite growth-inhibitory effects of
TNF (Fig. 6D–F). It also completely abolished the neurite
growth-inhibitory effects of overexpressed IKK in both SCG
(see Fig. 8A–C) and nodose neurons (Fig. 7A–C). Expression of
the S536A-p65 mutant did not promote neurite growth from
either SCG or nodose neurons cultured without neurotrophins
(data not shown). Together, these findings suggest that phos-
phorylation of p65 at S536 is required for the neurite growth-
inhibitory effects of enhancing NF-B signaling with either
TNF or IKK overexpression.
Figure 7. S536A-p65 abolishes IKK-induced neurite growth inhibition, and S536D-p65 inhibits neurite growth fromnodose
neurons. A–C, Total neurite length (A), number of branch points (B), and Sholl profiles (C) of the neurite arbors of P0 nodose
neurons transfected 3 h after plating with the YFP plasmid and either the pcDNA3.1 control plasmid, IKK plasmid, or the IKK
plasmid plus the S536A-p65 plasmid and cultured for an additional 24 h. D–F, Total neurite length (D), number of branch points
(E), and Sholl profiles (F ) of the neurite arbors of P0 nodose neurons transfected 3 h after platingwith the YFP plasmid and either
thepcDNA3.1 control plasmid, thep50plasmidplus thep65plasmid, or thep50plasmidplus the S536D-p65plasmid and cultured
for an additional 24 h. The combined results of three separate experiments of each kind are plotted (means and SEs of the data
from150neurons for each condition). Statistically significant differences fromcontrol-transfectedneurons are indicated (*p
0.05; **p 0.001).
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Phosphomimetic S536D-p65 mutant
inhibits neurite growth from SCG and
nodose neurons
As a final test of the importance of S536
phosphorylation in neurite growth inhibi-
tion, we transfected nodose neuronswith a
plasmid expressing a dominant-positive
phosphomimetic p65 mutant (S536D)
that behaves like constitutively active
phospho-S536-p65 (Sasaki et al., 2005).
Expression of this mutant had no effect on
neuronal survival (data not shown) and
also caused a more than twofold increase
in B reporter signal ( p  0.0001) (data
not shown). Whereas overexpression of
wild-type p65 together with p50 promoted
significant increases in neurite length and
branching of 65 and 30%, respectively, ex-
pression of S536D-p65 mutant together
with p50 led to significant decreases of 38
and 47%, respectively, relative to control-
transfected neurons (Fig. 7D,E). These
marked changes in neurite growth were
also clearly apparent in the corresponding
Sholl plots (Fig. 7F). In SCGneurons, neu-
rite growth inhibition was observed after
overexpression of either wild-type p65 and
p50 or S536D-p65 and p50 relative to
control-transfected neurons (Fig. 8D–F).
Together, these results demonstrate that
phosphomimetic modification of p65 on
S536 is sufficient to reverse the functional
role of NF-B in sensory neurons.
Discussion
Recent work has established a key role for
NF-B signaling in promoting the growth
of neural processes in the developing PNS and CNS. Blocking
NF-B signaling impairs pyramidal dendrite growth in the hip-
pocampus and reduces NGF-promoted neurite growth from
PC12 cells and BDNF-promoted neurite growth from nodose
ganglion sensory neurons (Sole et al., 2004; Gutierrez et al.,
2005). Most strikingly, CNTF-promoted neurite growth from
nodose neurons is virtually eliminated by inhibiting NF-B sig-
naling (Gallagher et al., 2007). In marked contrast to these stud-
ies, we show that blocking multiple steps in NF-B signaling in
neonatal sympathetic neurons does not affect neurite growth.
Dominant-negative IKK, S32/36A, and Y42F IB mutants,
nuclear translocation blockade with SN50 and sequestration of
activatedNF-B by decoy BDNAbring about large decreases in
NF-B transcriptional activity in these neurons, but have no ef-
fect on neurite arbor size and complexity. These findings together
with our demonstration that the constitutive level of NF-B sig-
naling in sympathetic neurons is no different to that in nodose
sensory neurons (data not shown) clearly indicate that constitu-
tive NF-B signaling in sympathetic neurons does not promote
neurite growth from these neurons.Moreover, enhancingNF-B
signaling in these neurons by overexpressing IKK, p65, or p65/
p50 or by TNF treatment greatly reduces neurite growth, indi-
cating thatNF-B signaling can exert a potent inhibitory effect on
neurite growth in these neurons.
In neonatal nodose neurons, our finding that overexpressing
p65/p50 increases neurite growth, whereas overexpressing IKK
strongly inhibits neurite growth, clearly demonstrates that
NF-B can promote or inhibit neurite growth in the same neu-
rons depending on themechanismof activation. Themuch lower
level of phosphorylated IKK in protein extracts of BDNF-
supported neonatal nodose neurons suggests that IKK activation
plays little or no role in the regulation of neurite growth by con-
stitutive NF-B activity in these neurons. This agrees with our
observation that expression of either dominant-negative IKK or
dominant-negative IKK has no effect on BDNF-promoted neu-
rite growth from these neurons (data not shown). Furthermore,
CNTF-promoted neurite growth from neonatal nodose neurons
engages an NF-B signaling pathway that, crucially, does not
require activation of the IKK complex (Gallagher et al., 2007).
Together, these data show that the positive regulation of neurite
growth by either an inducible or constitutive NF-B signal in
nodose neurons occurs through IKK-independent mechanisms.
In contrast to nodose neurons, Western blot analysis revealed
that sympathetic neurons possess high constitutively active IKK.
Accordingly, p65, a known substrate of IKK (Sakurai et al.,
1999), is constitutively phosphorylated at serine 536 in sympa-
thetic neurons, whereas nodose neurons contain barely detect-
able levels of phospho-S536-p65. The level of phospho-S536-p65
is markedly elevated in sympathetic neurons after TNF treat-
ment and IKK overexpression, and phospho-S536-p65 be-
comes abundantly detectable in nodose neurons overexpressing
IKK. This correlation between elevated phospho-S536-p65 and
Figure 8. S536A-p65 abolishes IKK-induced neurite growth inhibition, and S536D-p65 has a similar inhibitory effect to
wild-type p65 on neurite growth from SCG neurons.A–C, Total neurite length (A), number of branch points (B), and Sholl profiles
(C) of the neurite arbors of P0 SCG neurons transfected 3 h after plating with the YFP plasmid and either the pcDNA3.1 control
plasmid, IKK plasmid, or the IKK plasmid plus the S536A-p65 plasmid and cultured for an additional 24 h. D–F, Total neurite
length (D), number of branch points (E), and Sholl profiles (F ) of the neurite arbors of P0 SCG neurons transfected 3 h after plating
with the YFP plasmid and either the pcDNA3.1 control plasmid, the p50 plasmid plus the p65 plasmid, or the p50 plasmid plus the
S536D-p65 plasmid and cultured for an additional 24 h. The combined results of three separate experiments of each kind are
plotted (means and SEs of the data from150 neurons for each condition). Statistically significant difference from control-
transfected neurons is indicated (**p 0.001).
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neurite growth inhibition is causative because expressing a p65
protein with an alanine substitution at serine 536 prevents its
neurite growth-inhibitory effect as well as that of TNF and
IKK overexpression in sympathetic neurons and IKK overex-
pression in nodose neurons. Furthermore, expression of a
dominant-positive S536D-p65 mutant that has been shown to
behave like phospho-S536-p65 (Sakurai et al., 1999; Buss et al.,
2004), drastically reduces neurite growth, strongly suggesting
that phosphorylation of p65 at serine 536 is in itself sufficient to
trigger the reversal of NF-B function in the regulation of neurite
growth.
The importance of phospho-S536-p65 in switching NF-B
signaling from growth promoting to growth inhibitory explains
why p65/p50 overexpression in sympathetic and nodose neurons
has opposite effects on neurite growth. In sympathetic neurons,
constitutive activation of IKKwould be expected to bring about
this posttranslational modification in overexpressed p65,
whereas in nodose neurons overexpressed p65 remains unphos-
phorylated on this residue (Fig. 9). This raises the question of the
actual role played by the basal level of phospho-S536-p65 in sym-
pathetic neurons. Although our data demonstrate that augment-
ing NF-B activity in sympathetic neurons inhibits growth, its
blockade failed to enhance axonal growth. This might be because
the capacity of neurite elongation machinery is rate limiting in
sympathetic neurons under the present experimental conditions.
In this regard, we recently reported that NGF-promoted axon
growth and target innervation requires an autocrine signaling
loop in sympathetic neurons involving a member of the TNF
superfamily, glucocorticoid-induced TNF receptor related gene
(GITR), and its ligand, GITR ligand (GITRL) (O’Keeffe et al.,
2008). The level ofGITRL–GITR signaling in culture could there-
fore place a limit on the ability of these neurons to extend neu-
rites. Alternatively, it is possible that phospho-S536-p65 has to be
elevated above a certain threshold before it exerts an inhibitory
effect, and onlywhen the level of phospho-S536-p65 is elevated in
these neurons is growth retardation observed. This latter possi-
bility is consistent with the fact that the endogenous visible levels
of phospho-S536-p65 seem not to negatively influence NGF-
promoted growth in sympathetic neurons and that NGF neither
induces nor inhibits NF-B-dependent transcriptional activity in
neonate sympathetic neurons (data not shown).
We found that IKK but not IKK promoted p65 phosphor-
ylation and growth inhibition in SCG and nodose neurons. Al-
though both IKK and IKK have been shown to be equally
capable of phosphorylating p65 at serine 536, differences in the
relative importance of either IKKprotein in promoting p65 phos-
phorylation have also been described in different cellular systems
(Jeong et al., 2005; Lawrence et al., 2005). Although we focused
on the role of IKK in p65 phosphorylation, we cannot rule out
the potential involvement of other serine kinases modifying p65
in developing neurons. Serine 536 is known to be targeted by
several other kinases including RSK1, IKK, and TBK1 (Mettou-
chi et al., 1997; Sakurai et al., 1999, 2003; Fujita et al., 2003; Jiang
et al., 2003; Yang et al., 2003; Bohuslav et al., 2004; Buss et al.,
2004; Mattioli et al., 2004; Jeong et al., 2005; Adli and Baldwin,
2006). This raises the possibility that other signaling pathways
might influence the phosphorylation status of p65 in particular
neurons and hence modulate the function of NF-B on axonal
and dendritic growth. The schematic model shown in Figure 9
summarizes the proposed mechanism underlying the functional
switch for NF-B signaling based on the phosphorylation status
of p65 at S536.
The events after NF-B activation that inhibit or promote
growth of neural processes are unclear. NF-B activation induces
or represses the expression of many genes in different cellular
contexts (Hoffmann et al., 2006). Some NF-B-regulated genes
are potentially relevant in the control of neural process growth,
such as the neural cell adhesion molecule, tenascin-C, and 1
integrin (Mettouchi et al., 1997; Simpson and Morris, 2000;
Wang et al., 2003). It is possible that the opposing effects on
neurite growth of phosphorylated and nonphosphorylated S536
p65 could result from the regulation of different sets of genes.
Serine 536 is located within a C-terminal transactivation domain
of p65 (Viatour et al., 2005), and the consequences ofmutation at
this residue for p65 transcriptional activity differ according to the
promoter being analyzed. For example, S536A substitution sub-
stantially reduced the B-luciferase reporter signal in fibroblasts
in which IKK and/or IKK were activated in a variety of ways
(Madrid et al., 2000; Jiang et al., 2003; Yang et al., 2003;
O’Mahony et al., 2004). In contrast, S536A substitution did not
reduce p65 transcriptional activity in fibroblasts with respect to
TNF-mediated interleukin-6 (IL-6) induction (Okazaki et al.,
2003) and IL-1-mediated IL-8 induction (Buss et al., 2004).
Moreover, the S536D phosphomimetic p65mutant induced IL-8
transcription in the Jurkat T-cell line, whereas the S536A p65
mutant did not (Sasaki et al., 2005). These observations have led
to the proposal that phosphorylated S536 p65 and nonphospho-
rylated S536 p65 regulate the transcription of different sets of
genes (Sasaki et al., 2005). For this reason, it will be informative to
study the expression of NF-B-regulated genes in neurons under
conditions in which NF-B signaling has opposing actions on
neurite growth.
Figure 9. Schematic model showing the proposed mechanism underlying the opposing
effects of NF-B signaling on neurite growth. In nodose sensory neurons, IKK-independent
constitutive NF-B signaling in BDNF-supplemented cultures leads to a transcriptionally active
form of p65 that is not phosphorylated on S536 that promotes neurite growth. In SCG sympa-
thetic neurons, IKK-dependent enhanced NF-B signaling after TNF treatment leads to a
transcriptionally active formof p65 that is phosphorylated onS536 that inhibits neurite growth.
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In summary, our results demonstrate that NF-B can both
stimulate and inhibit neurite growth in developing neurons de-
pending on the phosphorylation status of p65. Although opposite
effects of NF-B signaling have been described in the regulation
of cell survival and cell death in different cellular systems
(Me´met, 2006; Schwabe and Brenner, 2007), to our knowledge
we provide the first demonstration of a reversal in NF-B func-
tion resulting from the phosphorylation of a single residue in an
active NF-B subunit. Our results will help to explain conflicting
data regarding seemingly diverging roles played byNF-B signal-
ing in the nervous system and provide additional support for the
importance of this signaling pathway in neural plasticity and
development.
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